C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof

Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102)
12/1999
12/16/1999	WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	WO1999064051A1 Novel antibacterial compounds
12/16/1999	WO1999064049A1 Novel antibacterial agents
12/16/1999	WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999	WO1999064047A1 Novel antiviral compounds
12/16/1999	WO1999064046A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999	WO1999064044A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999	WO1999064043A1 Muscarinic receptor antagonists
12/16/1999	WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999	WO1999064040A1 Novel polyene macrolide compounds and uses
12/16/1999	WO1999064039A1 Bradykinin antagonists
12/16/1999	WO1999064038A1 Novel analgesic agents
12/16/1999	WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999	WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	WO1999063999A1 H1-histamine receptor antagonists
12/16/1999	WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999	WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999	WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999	WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999	WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999	WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2321274A1 Novel antiviral compounds
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321191A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999	CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999	CA2321162A1 Novel antibacterial compounds
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2320241A1 Multivalent macrolide antibiotics
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319730A1 Bradykinin antagonists
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999	CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319174A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2316999A1 Inhibitors of hiv reverse transcriptase
12/16/1999	CA2315883A1 Muscarinic receptor antagonists
12/08/1999	EP0640101B1 Methods and reagents for diagnosis of autoantibodies
12/01/1999	EP0960119A1 T cell antigen receptor peptides
12/01/1999	EP0959895A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
11/1999
11/17/1999	EP0697884B1 Ligand precursors for incorporation into peptides
11/17/1999	CN1046537C Preparation of amino acid low peptide
11/11/1999	WO1999041608A3 Interaction between cyclin d1 and steroid receptor co-activators
11/04/1999	CA2329778A1 Improvements in or relating to diagnostic/therapeutic agents
11/02/1999	CA1340809C Process for producing a novel antifungal product from pediococcus sp.
10/1999
10/28/1999	WO1999054728A2 Method of predicting receptor modulating activity
10/07/1999	WO1999050664A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999	CA2326573A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
09/1999
09/28/1999	US5958424 Recombinant chicken anemia virus particle
09/21/1999	CA2045761C Ws7622a mono- or di- sulfate, process for preparation thereof and use thereof
09/01/1999	EP0939121A2 TNF-binding proteins
08/1999
08/19/1999	WO1999041608A2 Interaction between cyclin d1 and steroid receptor co-activators
08/19/1999	CA2319167A1 Interaction between cyclin d1 and steroid receptor co-activators
08/17/1999	US5939527 Tetrapeptides as antitumor agents
08/03/1999	US5932476 Cloning of chicken anemia virus DNA
07/1999
07/29/1999	WO1999037665A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof
07/29/1999	WO1999037664A1 Novel peptides having biological activity
07/29/1999	CA2317492A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof
07/20/1999	CA1340656C Membrane anchor/active compound conjugate, its preparation and its use
07/07/1999	EP0927191A2 Anti-inflammatory peptides and uses thereof
07/07/1999	EP0927190A1 Central nervous system-derived immune privilege factor and uses thereof
07/01/1999	WO1999032498A1 Antibiotic tkr2999, process for the preparation thereof and microbe
06/1999
06/17/1999	WO1999015549A3 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine
06/09/1999	EP0920325A2 Tetrapeptide derivatives of dolastatin as antitumor agents
06/08/1999	US5910404 Amino acid sequence of peptide mimetic; for screening blood and blood products; use as immunogens
05/1999
05/19/1999	EP0500921B1 Na-k-atpase inhibiting natriuretic substances
04/1999
04/07/1999	EP0906419A2 Peptide ligands of the urokinase receptor
04/01/1999	WO1999015549A2 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine
04/01/1999	WO1998054577A9 Cyclic peptide libraries and methods of use thereof to identify binding motifs
03/1999
03/31/1999	EP0905246A1 Cloning of chicken anaemia DNA
03/31/1999	EP0904095A1 Chimeric isoprenoid synthases and uses thereof
03/02/1999	US5876712 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated

1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22